- Home
- KTB vs CRNX Comparison
KTB vs CRNX Comparison
Compare KTB & CRNX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | KTB | CRNX |
|---|---|---|
| Founded | 2018 | 2008 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Apparel | Biotechnology: Pharmaceutical Preparations |
| Sector | Consumer Discretionary | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 3.7B | 4.5B |
| IPO Year | 2018 | 2018 |
Fundamental Metrics
Financial Performance| Metric | KTB | CRNX |
|---|---|---|
| Price | $73.20 | $38.23 |
| Analyst Decision | Strong Buy | Strong Buy |
| Analyst Count | 9 | 9 |
| Target Price | ★ $99.67 | $74.78 |
| AVG Volume (30 Days) | 898.0K | ★ 900.2K |
| Earning Date | 06-03-2026 | 06-01-2026 |
| Dividend Yield | ★ 2.78% | N/A |
| EPS Growth | ★ N/A | N/A |
| EPS | ★ 4.05 | N/A |
| Revenue | ★ $2,097,839,000.00 | $1,039,000.00 |
| Revenue This Year | $10.42 | $730.30 |
| Revenue Next Year | $3.62 | $179.48 |
| P/E Ratio | $18.81 | ★ N/A |
| Revenue Growth | ★ N/A | N/A |
| 52 Week Low | $50.00 | $24.10 |
| 52 Week High | $87.00 | $57.99 |
Technical Indicators
Market Signals| Indicator | KTB | CRNX |
|---|---|---|
| Relative Strength Index (RSI) | 59.15 | 26.66 |
| Support Level | $68.96 | $33.23 |
| Resistance Level | $78.28 | $45.32 |
| Average True Range (ATR) | 3.47 | 1.83 |
| MACD | 0.77 | -0.36 |
| Stochastic Oscillator | 60.67 | 7.98 |
Price Performance
Historical ComparisonAbout KTB Kontoor Brands Inc.
Kontoor Brands Inc is a lifestyle apparel company. It is engaged in designing, manufacturing, sourcing, marketing, and distribution of its portfolio of brands, including Wrangler and Lee. It manufactures its products in owned and leased facilities and distributes the products through both brick-and-mortar and e-commerce retailers. The Company has two reportable segments: Wrangler and Lee. It generates the majority of its revenue from the Wrangler segment. The company's geographical segments are the United States and International, of which the majority of its revenue comes from the United States.
About CRNX Crinetics Pharmaceuticals Inc.
Crinetics Pharmaceuticals Inc is a clinical-stage pharmaceutical company focused on the discovery, development, and commercialization of novel therapeutics for rare endocrine diseases and endocrine-related tumors. Its products include Paltusotine and Atumelnant.